Your browser doesn't support javascript.
loading
ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon.
Hartmann, Sylvia; Yasmeen, Summaira; Jacobs, Benjamin M; Denaxas, Spiros; Pirmohamed, Munir; Gamazon, Eric R; Caulfield, Mark J; Hemingway, Harry; Pietzner, Maik; Langenberg, Claudia.
  • Hartmann S; Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Yasmeen S; Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Jacobs BM; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Denaxas S; Institute of Health Informatics, University College London, London, UK.
  • Pirmohamed M; Health Data Research UK, London, UK.
  • Gamazon ER; British Heart Foundation Data Science Centre, London, UK.
  • Caulfield MJ; National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK.
  • Hemingway H; Division of Genetic Medicine and Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
  • Pietzner M; William Harvey Research Institute, Queen Mary University of London, London, UK.
Nat Commun ; 14(1): 6156, 2023 10 12.
Article en En | MEDLINE | ID: mdl-37828025

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Raynaud / Estudio de Asociación del Genoma Completo Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Raynaud / Estudio de Asociación del Genoma Completo Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article